Skip to main content

Meet the Analyst: Dr. Tara Speranza, Bell Potter Analyst Part 2

Grady Wulff
February 23, 2023

Continue on to learn about the remaining stocks, Microba Life Sciences (ASX:MAP) and Monash IVF (ASX:MVF), as well as what to expect from these companies in 2023.

In this video, Dr. Tara discusses:
– (0:34) Impacts of Ferring’s FDA approval on Microba
– (5:30) Drivers behind Microba’s increase in revenue
– (7:12) What 2023 looks like for Monash IVF
– (8:39) Monash IVF’s rating
– (11:45) Monash IVF’s impact from legal action

Note: This interview was filmed on 7 February 2023.

Market Update 18 July

Julia Lee
July 18, 2016

Market Update 15 July

Julia Lee
July 15, 2016

Market Update 14 July

Julia Lee
July 14, 2016

Market Update 13 July

Julia Lee
July 13, 2016

Market Update

Julia Lee
July 11, 2016

Market Update

Julia Lee
July 8, 2016

Market Update

Julia Lee
July 7, 2016

CEO Interview Series: India Fund

Bell Direct
July 7, 2016

Market Update 6 June

Julia Lee
July 6, 2016

Market Update

Julia Lee
July 4, 2016